X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001798443 Kalif Eliyahu Sharon C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, Chief Financial Officer Ordinary Shares 2023-03-04 4 M 0 33512 A 112900 D Ordinary Shares 2023-03-05 4 M 0 21387 A 134287 D Restricted Share Units 2023-03-03 4 A 0 199202 0.00 A Ordinary Shares 199202 199202 D Restricted Share Units 2023-03-04 4 M 0 33512 0.00 D Ordinary Shares 33512 100536 D Restricted Share Units 2023-03-05 4 M 0 21387 0.00 D Ordinary Shares 21387 42777 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 49,800 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 49,802 vesting on March 3, 2027. Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026. Restricted share units were granted on March 5, 2021, with 21,387 vested on each of March 5, 2022 and March 5, 2023, 21,387 vesting on March 5, 2024, and 21,390 vesting on March 5, 2025. /s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif 2023-03-07